ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

ClinicalTrials.gov ID: NCT04462770

Public ClinicalTrials.gov record NCT04462770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants With Dravet Syndrome (ARGUS Trial)

Study identification

NCT ID
NCT04462770
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Epygenix
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Clemizole HCl Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2020
Primary completion
Mar 31, 2027
Completion
Apr 30, 2029
Last update posted
May 13, 2026

2020 – 2029

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 Active, not recruiting
Arkansas Children's Hospital Little Rock Arkansas 72202 Active, not recruiting
Children's Hospital of Los Angeles Los Angeles California 90027 Terminated
University of California Irvine Orange California 92868 Recruiting
UCSF Medical Center San Francisco California 94158 Recruiting
Yale University School of Medicine New Haven Connecticut 06510 Not yet recruiting
The Nemours Foundation Wilmington Delaware 19803 Terminated
Rare Disease Research FL Kissimmee Florida 34746 Recruiting
Pediatric Neurology and Epilepsy Specialists Winter Park Florida 32789 Recruiting
Clinical Integrative Research Center of Atlanta (CIRCA) Atlanta Georgia 30328 Withdrawn
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 Terminated
Norton Children's Research Institute Louisville Kentucky 40202 Recruiting
University of Michigan- Mott Children's Hospital Ann Arbor Michigan 48109 Terminated
Children's Nebraska Omaha Nebraska 68114 Recruiting
Northeast Regional Epilepsy Group Hackensack New Jersey 07601 Terminated
Neurology Center for Epilepsy and Seizures Marlboro New Jersey 07746 Active, not recruiting
Weill Cornell Medical Center New York New York 10021 Recruiting
Northwell Health - Lenox Hill Hospital New York New York 10075 Not yet recruiting
Duke University Health System Durham North Carolina 27710 Recruiting
Science 37 Morrisville North Carolina 27560 Active, not recruiting
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 Recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Nationwide Children's Hospital Columbus Ohio 43205 Withdrawn
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
Le Bonheur Children's Hospital Memphis Tennessee 38103 Terminated
Child Neurology Consultants of Austin Austin Texas 78757 Recruiting
UT Southwestern/Children's Health Dallas Texas 75207 Withdrawn
University of Utah Salt Lake City Utah 84112 Recruiting
Seattle Children's Hospital Seattle Washington 98105 Recruiting
Medical College of Wisconsin, Children's Wisconsin Milwaukee Wisconsin 53266 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04462770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04462770 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →